LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 4 von insgesamt 4

Suchoptionen

  1. Artikel ; Online: Primary and secondary immune thrombocytopenia (ITP): Time for a rethink.

    González-López, Tomás José / Provan, Drew / Bárez, Abelardo / Bernardo-Gutiérrez, Angel / Bernat, Silvia / Martínez-Carballeira, Daniel / Jarque-Ramos, Isidro / Soto, Inmaculada / Jiménez-Bárcenas, Reyes / Fernández-Fuertes, Fernando

    Blood reviews

    2023  Band 61, Seite(n) 101112

    Abstract: There are not many publications that provide a holistic view of the management of primary and secondary ITP as a whole, reflecting the similarities and differences between the two. Given the lack of major clinical trials, we believe that comprehensive ... ...

    Abstract There are not many publications that provide a holistic view of the management of primary and secondary ITP as a whole, reflecting the similarities and differences between the two. Given the lack of major clinical trials, we believe that comprehensive reviews are much needed to guide the diagnosis and treatment of ITP today. Therefore, our review addresses the contemporary diagnosis and treatment of ITP in adult patients. With respect to primary ITP we especially focus on establishing the management of ITP based on the different and successive lines of treatment. Life-threatening situations, "bridge therapy" to surgery or invasive procedures and refractory ITP are also comprehensively reviewed here. Secondary ITP is studied according to its pathogenesis by establishing three major differential groups: Immune Thrombocytopenia due to Central Defects, Immune Thrombocytopenia due to Blocked Differentiation and Immune Thrombocytopenia due to Defective Peripheral Immune Response. Here we provide an up-to-date snapshot of the current diagnosis and treatment of ITP, including a special interest in addressing rare causes of this disease in our daily clinical practice. The target population of this review is adult patients only and the target audience is medical professionals.
    Mesh-Begriff(e) Adult ; Humans ; Purpura, Thrombocytopenic, Idiopathic/diagnosis ; Purpura, Thrombocytopenic, Idiopathic/etiology ; Purpura, Thrombocytopenic, Idiopathic/therapy ; Thrombocytopenia ; Platelet Count ; Receptors, Thrombopoietin ; Thrombopoietin/therapeutic use
    Chemische Substanzen Receptors, Thrombopoietin ; Thrombopoietin (9014-42-0)
    Sprache Englisch
    Erscheinungsdatum 2023-06-29
    Erscheinungsland England
    Dokumenttyp Journal Article ; Review
    ZDB-ID 639015-8
    ISSN 1532-1681 ; 0268-960X
    ISSN (online) 1532-1681
    ISSN 0268-960X
    DOI 10.1016/j.blre.2023.101112
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Syncope as a manifestation of mast cell activation disorder.

    Perales Chordá, Carolina / Fabregat Nebot, Sandra / Moral Moral, Pedro / Jarque Ramos, Isidro / Hernández Fernandez de Rojas, Dolores

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

    2015  Band 114, Heft 2, Seite(n) 153–154

    Mesh-Begriff(e) Adult ; Anaphylaxis/blood ; Anaphylaxis/diagnosis ; Anti-Inflammatory Agents, Non-Steroidal/adverse effects ; Humans ; Male ; Mast Cells/immunology ; Mastocytosis/blood ; Mastocytosis/diagnosis ; Syncope/blood ; Syncope/diagnosis ; Troponin/blood ; Tryptases/blood
    Chemische Substanzen Anti-Inflammatory Agents, Non-Steroidal ; Troponin ; Tryptases (EC 3.4.21.59)
    Sprache Englisch
    Erscheinungsdatum 2015-02
    Erscheinungsland United States
    Dokumenttyp Case Reports ; Letter
    ZDB-ID 1228189-x
    ISSN 1534-4436 ; 0003-4738 ; 1081-1206
    ISSN (online) 1534-4436
    ISSN 0003-4738 ; 1081-1206
    DOI 10.1016/j.anai.2014.11.019
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel: Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI).

    Mingot-Castellano, María Eva / Canaro Hirnyk, Mariana / Sánchez-González, Blanca / Álvarez-Román, María Teresa / Bárez-García, Abelardo / Bernardo-Gutiérrez, Ángel / Bernat-Pablo, Silvia / Bolaños-Calderón, Estefanía / Butta-Coll, Nora / Caballero-Navarro, Gonzalo / Caparrós-Miranda, Isabel Socorro / Entrena-Ureña, Laura / Fernández-Fuertes, Luis Fernando / García-Frade, Luis Javier / Gómez Del Castillo, María Del Carmen / González-López, Tomás José / Grande-García, Carlos / Guinea de Castro, José María / Jarque-Ramos, Isidro /
    Jiménez-Bárcenas, Reyes / López-Ansoar, Elsa / Martínez-Carballeira, Daniel / Martínez-Robles, Violeta / Monteagudo-Montesinos, Emilio / Páramo-Fernández, José Antonio / Perera-Álvarez, María Del Mar / Soto-Ortega, Inmaculada / Valcárcel-Ferreiras, David / Pascual-Izquierdo, Cristina

    Journal of clinical medicine

    2023  Band 12, Heft 20

    Abstract: Primary immune thrombocytopenia (ITP) is a complex autoimmune disease whose hallmark is a deregulation of cellular and humoral immunity leading to increased destruction and reduced production of platelets. The heterogeneity of presentation and clinical ... ...

    Abstract Primary immune thrombocytopenia (ITP) is a complex autoimmune disease whose hallmark is a deregulation of cellular and humoral immunity leading to increased destruction and reduced production of platelets. The heterogeneity of presentation and clinical course hampers personalized approaches for diagnosis and management. In 2021, the Spanish ITP Group (GEPTI) of the Spanish Society of Hematology and Hemotherapy (SEHH) updated a consensus document that had been launched in 2011. The updated guidelines have been the reference for the diagnosis and management of primary ITP in Spain ever since. Nevertheless, the emergence of new tools and strategies makes it advisable to review them again. For this reason, we have updated the main recommendations appropriately. Our aim is to provide a practical tool to facilitate the integral management of all aspects of primary ITP management.
    Sprache Englisch
    Erscheinungsdatum 2023-10-10
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm12206422
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Los aspectos epidemiológicos cambiantes de la candidemia y sus implicaciones clinicoterapéuticas.

    Salavert Lletí, Miguel / Jarque Ramos, Isidro / Pemán García, Javier

    Enfermedades infecciosas y microbiologia clinica

    2006  Band 24 Suppl 1, Seite(n) 36–45

    Abstract: Candida species are a major cause of healthcare-related bloodstream and invasive infections. Studies assessing nosocomial bloodstream infections during the two last decades ranked Candida species as the fourth most common nosocomial bloodstream pathogen. ...

    Titelübersetzung Changing epidemiological aspects of candidemia and their clinical and therapeutic implications.
    Abstract Candida species are a major cause of healthcare-related bloodstream and invasive infections. Studies assessing nosocomial bloodstream infections during the two last decades ranked Candida species as the fourth most common nosocomial bloodstream pathogen. The incidence of Candida species has risen steadily during this period due to the increase in the number and type of patients at risk for these yeasts. Infections caused by Candida are especially frequent and serious in onco-hematological patients. Over the past decade, the introduction of azole antifungals as prophylactic agents, together with other factors, has led to a shift in the species of Candida that cause infection. During the period under review (1996 to 2005) several studies have confirmed the impact of antifungal prophylaxis with azoles on the emergence of Candida species other than Candida albicans. The widespread use of fluconazole has contributed to a relative decrease in the prevalence of C. albicans, while species inherently less susceptible, such as Candida glabrata and Candida krusei, appear to be isolated with greater frequency. Moreover, laboratory studies to determine the antifungal susceptibilities and virulence of non-albicans Candida species have enabled the design of microbe-specific management strategies. More of these studies will be necessary as we enter an age in which multiple antifungal compounds (echinocandins, new azoles) will become available for clinical use in invasive candidiasis or candidemia. The present review aims to highlight the different trends in the incidence, distribution and behavior of Candida bloodstream infections in the distinct types of patients at risk.
    Mesh-Begriff(e) Candidemia/diagnosis ; Candidemia/drug therapy ; Candidemia/epidemiology ; Humans ; Risk Factors
    Sprache Spanisch
    Erscheinungsdatum 2006-11-17
    Erscheinungsland Spain
    Dokumenttyp English Abstract ; Journal Article ; Review
    ZDB-ID 1070941-1
    ISSN 1578-1852 ; 0213-005X
    ISSN (online) 1578-1852
    ISSN 0213-005X
    DOI 10.1157/13094277
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang